Clinical Trial Update: LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 dose-finding clinical trial update for LFB-R603 in patients with advanced stage Chronic Lymphocytic Leukemia (Phase 1; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• LFB-R603 (LFB-R603)

Snippet

Sponsor: Laboratoire français de Fractionnement et de Biotechnologies | Conditions: Chronic Lymphocytic Leukemia | Phase 1 | Status: COMPLETED